PCN patients mobilized after CAD chemotherapy required less plerixafor administration than patients mobilized in only with G-CSF, p = 0.01, while there was no difference in the need for plerixafor when comparing lymphoma patients mobilized from salvage regimens and those mobilized only using cytokines p = 0.46. Here, CSF3 is linked to lymphoma.